prednisolone has been researched along with Scleroderma, Diffuse in 13 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Scleroderma, Diffuse: A rapid onset form of SYSTEMIC SCLERODERMA with progressive widespread SKIN thickening over the arms, the legs and the trunk, resulting in stiffness and disability.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a case of a 70-year-old woman, who was diagnosed with diffuse cutaneous systemic sclerosis and psoriasis vulgaris and was treated with oral azathioprine (50 mg/d) and prednisolone (10 mg/d), topical corticosteroids, and calcipotriols." | 4.31 | Case of systemic sclerosis overlapping with psoriasis. ( Hua, X; Rao, L; Tan, H; Xie, Y; Zhou, P, 2023) |
| "One patient with long-standing fibrosing alveolitis was later added to our cohort." | 2.72 | Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease. ( Andonopoulos, AP; Bounas, A; Liossis, SN, 2006) |
| "Most patients were on corticosteroid treatment." | 2.43 | Necrotizing fasciitis in rheumatic diseases. ( Chan, TM; Lau, CS; Mok, MY; Tang, WM; Wong, SY; Wong, WS, 2006) |
| "We report a rare case of diffuse systemic sclerosis (SSc) evolving into diffuse SSc/systemic lupus erythematosus (SLE) overlap syndrome." | 1.38 | Juvenile diffuse systemic sclerosis/systemic lupus erythematosus overlap syndrome--a case report. ( Fu, LS; Lin, HK; Wang, JD, 2012) |
| "Prednisolone was eventually discontinued; however, 10 months after discontinuation, anti-topo I reemerged and increased to 102." | 1.36 | Re-emergence of anti-topoisomerase I antibody with exacerbated development of skin sclerosis in a patient with systemic sclerosis. ( Fujimoto, M; Hamaguchi, Y; Hasegawa, M; Matsushita, T; Takehara, K, 2010) |
| "Pericarditis is seen in half of patients with SSc and rarely with SjS, and is usually asymptomatic." | 1.33 | [A case of systemic sclerosis and Sjogren's syndrome with cardiac tamponade due to steroid-responsive pericarditis]. ( Akiyama, O; Hagiwara, K; Kobayashi, S; Oominami, SY; Sato, T; Souma, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Griffiths-Jones, DJ | 1 |
| Garcia, YS | 1 |
| Ryder, WD | 1 |
| Pauling, JD | 1 |
| Hall, F | 1 |
| Lanyon, P | 1 |
| Bhat, S | 1 |
| Douglas, K | 1 |
| Gunawardena, H | 1 |
| Akil, M | 1 |
| Anderson, M | 1 |
| Griffiths, B | 1 |
| Del Galdo, F | 1 |
| Youssef, H | 1 |
| Madhok, R | 1 |
| Arthurs, B | 1 |
| Buch, M | 1 |
| Fligelstone, K | 1 |
| Zubair, M | 1 |
| Mason, JC | 1 |
| Denton, CP | 1 |
| Herrick, AL | 1 |
| Xie, Y | 1 |
| Hua, X | 1 |
| Tan, H | 1 |
| Rao, L | 1 |
| Zhou, P | 1 |
| Suga, K | 1 |
| Yamashita, H | 1 |
| Takahashi, Y | 1 |
| Katagiri, D | 1 |
| Hinoshita, F | 1 |
| Kaneko, H | 1 |
| Miguel, D | 1 |
| Darr-Foit, S | 1 |
| Tittelbach, J | 1 |
| Elsner, P | 1 |
| Hamaguchi, Y | 1 |
| Fujimoto, M | 1 |
| Hasegawa, M | 2 |
| Matsushita, T | 1 |
| Takehara, K | 2 |
| Maehana, T | 1 |
| Mizuno, T | 1 |
| Muto, M | 1 |
| Nishiyama, N | 1 |
| Yanase, M | 1 |
| Lin, HK | 1 |
| Wang, JD | 1 |
| Fu, LS | 1 |
| Maeshima, E | 1 |
| Nishimoto, T | 1 |
| Yamashita, M | 1 |
| Mune, M | 1 |
| Yukawa, S | 1 |
| WIEME, RJ | 1 |
| Sato, S | 1 |
| Liossis, SN | 1 |
| Bounas, A | 1 |
| Andonopoulos, AP | 1 |
| Mok, MY | 1 |
| Wong, SY | 1 |
| Chan, TM | 1 |
| Tang, WM | 1 |
| Wong, WS | 1 |
| Lau, CS | 1 |
| Sato, T | 1 |
| Oominami, SY | 1 |
| Souma, T | 1 |
| Hagiwara, K | 1 |
| Kobayashi, S | 1 |
| Akiyama, O | 1 |
2 reviews available for prednisolone and Scleroderma, Diffuse
| Article | Year |
|---|---|
[Scleroderma-like skin sclerosis induced by docetaxel chemotherapy for hormone refractory prostate cancer: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Resistance, Neoplasm; Humans; | 2010 |
Necrotizing fasciitis in rheumatic diseases.
Topics: Adult; Aeromonas; Animals; Anti-Bacterial Agents; Arthritis, Infectious; Arthritis, Rheumatoid; Arth | 2006 |
2 trials available for prednisolone and Scleroderma, Diffuse
| Article | Year |
|---|---|
A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS).
Topics: COVID-19; Double-Blind Method; Humans; Pain; Pandemics; Prednisolone; Scleroderma, Diffuse; Treatmen | 2023 |
Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; Gluco | 2006 |
9 other studies available for prednisolone and Scleroderma, Diffuse
| Article | Year |
|---|---|
Case of systemic sclerosis overlapping with psoriasis.
Topics: Aged; Azathioprine; Female; Humans; Prednisolone; Psoriasis; Scleroderma, Diffuse; Scleroderma, Syst | 2023 |
Therapeutic efficacy of combined glucocorticoid, intravenous cyclophosphamide, and double-filtration plasmapheresis for skin sclerosis in diffuse systemic sclerosis.
Topics: Administration, Oral; Aged; Combined Modality Therapy; Cyclophosphamide; Female; Glucocorticoids; Hu | 2020 |
Trigeminal neuropathy responding to systemic corticosteroids and methotrexate in a patient with diffuse cutaneous systemic sclerosis.
Topics: Female; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Prednisolone; | 2017 |
Re-emergence of anti-topoisomerase I antibody with exacerbated development of skin sclerosis in a patient with systemic sclerosis.
Topics: Adult; DNA Topoisomerases, Type I; Female; Glucocorticoids; Humans; Prednisolone; Scleroderma, Diffu | 2010 |
Juvenile diffuse systemic sclerosis/systemic lupus erythematosus overlap syndrome--a case report.
Topics: Adolescent; Antihypertensive Agents; Arthritis; Autoantibodies; Biomarkers; Deglutition Disorders; D | 2012 |
Progressive systemic sclerosis-polymyositis overlap syndrome with eosinophilic pleural effusion.
Topics: Anti-Inflammatory Agents; C-Reactive Protein; Creatine Kinase; Eosinophilia; Humans; Male; Middle Ag | 2003 |
[Favorable effects of prednisolone (deltacortril) in a case of progressive diffuse scleroderma].
Topics: Basidiomycota; Prednisolone; Scleroderma, Diffuse; Scleroderma, Localized; Scleroderma, Systemic; St | 1956 |
Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.
Topics: Adult; Case-Control Studies; Cells, Cultured; Female; Humans; Leukocytes, Mononuclear; Male; Middle | 2004 |
[A case of systemic sclerosis and Sjogren's syndrome with cardiac tamponade due to steroid-responsive pericarditis].
Topics: Aged; Cardiac Tamponade; Female; Humans; Pericarditis; Prednisolone; Scleroderma, Diffuse; Sjogren's | 2006 |